Clinical Trial Update: A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating the combination of JNJ-78278343 and JNJ-95298177 for prostate cancer, with the trial currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• JNJ-78278343
• JNJ-95298177

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: RECRUITING